4-环庚基苯酚 | 75120-08-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 4-环庚基苯酚
• 英文名称: 4-cycloheptylphenol
• 英文别名: 4-Cycloheptyl-phenol；Cycloheptyl-1-phenol；Phenol, 4-cycloheptyl-
• CAS: 75120-08-0
• 化学式: C₁₃H₁₈O
• 分子量: 190.285
• InChiKey: AXIVAMNNBGCFOQ-UHFFFAOYSA-N

物化性质

• 熔点：
  105 °C
• 沸点：
  319.0±21.0 °C(Predicted)
• 密度：
  1.018±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-环庚基苯酚 在 palladium on activated charcoal 氢气 、 potassium carbonate 作用下， 以 甲醇 、 邻二氯苯 、 丙酮 为溶剂， 生成 4-Cycloheptyl-2-propyl-phenol
  参考文献：
  名称：

  Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists

  摘要：

  A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling. (C) 2003 Published by Elsevier Ltd.

  DOI：

  10.1016/s0960-894x(03)00785-6
• 作为产物：
  描述：

  1-(4-甲氧基苯基)环庚烯 在 氢溴酸 、 溶剂黄146 作用下， 生成 4-环庚基苯酚
  参考文献：
  名称：

  58.芳核的烷基化。第九部分 环戊基化和环庚基化

  摘要：

  DOI：

  10.1039/jr9630000373

文献信息

• [EN] MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS<br/>[FR] ANTIBIOTIQUES MACROCYCLIQUES À LARGE SPECTRE
  申请人：RQX PHARMACEUTICALS INC

  公开号：WO2018149419A1

  公开（公告）日：2018-08-23

  Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.

  本文提供了抗菌化合物，其中在某些实施例中，这些化合物具有广谱生物活性。在各种实施例中，这些化合物通过抑制细菌类型1信号肽酶（SpsB）发挥作用，这是细菌中的一种必需蛋白质。还提供了使用所述化合物的药物组合物和治疗方法。
• [EN] SUBSTITUTED (4'-HYDROXYPHENYL)CYCLOALKANE COMPOUNDS AND USES THEREOF AS SELECTIVE AGONISTS OF THE ESTROGEN RECEPTOR BETA ISOFORM<br/>[FR] COMPOSÉS SUBSTITUÉS DE (4'-HYDROXYPHENYL)CYCLOALKANE ET LEURS UTILISATIONS EN TANT QU'AGONISTES SÉLECTIFS DE L'ISOFORME BÊTA DU RÉCEPTEUR D'ŒSTROGÈNES
  申请人：UNIV MARQUETTE

  公开号：WO2015077611A1

  公开（公告）日：2015-05-28

  Disclosed are substituted (4'-hydroxylphenyl)cycloalkane compounds and there use as selective agonists of the estrogen receptor beta isoform (ΕΚβ). The disclosed compounds may be formulated as pharmaceutical compositions and administered to treat diseases associated with ERβ activity, such as proliferative diseases and disorders and/or psychiatric diseases or disorders.

  本文披露了替代的(4'-羟基苯基)环烷化合物及其作为雌激素受体β异构体（ERβ）的选择性激动剂的用途。所披露的化合物可以制成药物组合物，并用于治疗与ERβ活性相关的疾病，如增生性疾病和紊乱以及精神疾病或紊乱。
• The Tropylation of Polyhydric Phenols and the Dehydrogenation of Their Products
  作者：Kazuko Takahashi

  DOI：10.1246/bcsj.40.1462

  日期：1967.6

  polyhydric phenols, such as guaiacol, catechol, resorcinol, hydroquinone, 2, 6-dimethoxyphenol, pyrogallol and phloroglucinol, has been carried out. These polyhydric phenols were quite reactive with ethyl tropyl ether or with tropylium ion, and gave mono-, di-, or sometimes tri-tropyl derivatives. The dehydrogenation of tropylpolyhydric phenol methyl ethers gave stable aryltropilium ions. The methoxyphenyltropones

  已经进行了愈创木酚、儿茶酚、间苯二酚、对苯二酚、2,6-二甲氧基苯酚、连苯三酚和间苯三酚等多元酚的转酰化反应。这些多元酚与乙基托醚或托鎓离子具有很强的反应性，并产生单、二或有时三托基衍生物。tropylpolyhydric phenolmethyl ethers 的脱氢得到稳定的aryltropilium 离子。甲氧基苯基托酮和甲氧基苯基托酚酮也以良好的产率从 4-甲氧基苯基托鎓离子开始合成。
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
  申请人：Tsubouchi Hidetsugu

  公开号：US20080119478A1

  公开（公告）日：2008-05-22

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种由下述通式（1）表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物： 在上述式（1）中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R1和—(CH2)nR2可以与相邻的碳原子形成如下式（30）所示的螺环，其中，在下式中，RRR代表可能在哌啶环上具有取代基的哌啶基： （30）且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。